• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.

作者信息

Molina-Garrido M J, Guillén-Ponce C

出版信息

Br J Cancer. 2011 Jan 4;104(1):224-5; author reply 226. doi: 10.1038/sj.bjc.6606037. Epub 2010 Dec 14.

DOI:10.1038/sj.bjc.6606037
PMID:21157451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3039811/
Abstract
摘要

相似文献

1
Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.关于“卡培他滨和贝伐单抗作为老年转移性结直肠癌患者的一线治疗”的评论
Br J Cancer. 2011 Jan 4;104(1):224-5; author reply 226. doi: 10.1038/sj.bjc.6606037. Epub 2010 Dec 14.
2
Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm.贝伐单抗治疗晚期结直肠癌：对当前范式的挑战。
J Clin Oncol. 2008 Oct 1;26(28):4693-4; author reply 4694-5. doi: 10.1200/JCO.2008.18.8060.
3
Targeted therapy for advanced colorectal cancer--more is not always better.晚期结直肠癌的靶向治疗——并非越多越好。
N Engl J Med. 2009 Feb 5;360(6):623-5. doi: 10.1056/NEJMe0809343.
4
Chemotherapy and immunotherapy in metastatic colorectal cancer.转移性结直肠癌的化疗与免疫治疗
N Engl J Med. 2009 May 14;360(20):2134; author reply 2135-6. doi: 10.1056/NEJMc090489.
5
Chemotherapy and immunotherapy in metastatic colorectal cancer.
N Engl J Med. 2009 May 14;360(20):2135; author reply 2135-6.
6
Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer?
Nat Rev Clin Oncol. 2010 Oct;7(10):556-7. doi: 10.1038/nrclinonc.2010.140.
7
[Metastatic colorectal cancer: adjournments from ESMO 2006].[转移性结直肠癌：2006年欧洲肿瘤内科学会会议延期内容]
Tumori. 2006 Nov-Dec;92(6):1-12. doi: 10.1177/030089160609200627.
8
Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy.接受卡培他滨联合治疗的转移性结直肠癌患者的血液学参数
Asian Pac J Cancer Prev. 2014;15(1):253-6. doi: 10.7314/apjcp.2014.15.1.253.
9
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.卡培他滨联合贝伐珠单抗作为老年转移性结直肠癌一线治疗方案的研究
Br J Cancer. 2010 May 11;102(10):1468-73. doi: 10.1038/sj.bjc.6605663. Epub 2010 Apr 27.
10
Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.XELOX 联合贝伐珠单抗作为转移性结直肠癌日本患者一线治疗的 I/II 期研究。
Jpn J Clin Oncol. 2010 Oct;40(10):913-20. doi: 10.1093/jjco/hyq069. Epub 2010 May 12.

本文引用的文献

1
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy.老年综合评估对 70 岁以上接受化疗患者的预测价值。
Crit Rev Oncol Hematol. 2011 Aug;79(2):205-12. doi: 10.1016/j.critrevonc.2010.05.009. Epub 2010 Aug 14.
2
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.卡培他滨联合贝伐珠单抗作为老年转移性结直肠癌一线治疗方案的研究
Br J Cancer. 2010 May 11;102(10):1468-73. doi: 10.1038/sj.bjc.6605663. Epub 2010 Apr 27.
3
Development of a cancer-specific Comprehensive Geriatric Assessment in a University Hospital in Spain.在西班牙的一所大学医院开发癌症特异性综合老年评估。
Crit Rev Oncol Hematol. 2011 Feb;77(2):148-61. doi: 10.1016/j.critrevonc.2010.02.006. Epub 2010 Mar 29.
4
Comprehensive geriatric assessment for older patients with cancer.老年癌症患者的综合老年评估
J Clin Oncol. 2007 May 10;25(14):1824-31. doi: 10.1200/JCO.2007.10.6559.
5
Aging, frailty, and chemotherapy.衰老、虚弱与化疗。
Cancer Control. 2007 Jan;14(1):7-12. doi: 10.1177/107327480701400102.
6
The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation.用于老年癌症患者预筛查的简化综合老年评估（aCGA）：评分与解读
Crit Rev Oncol Hematol. 2006 Sep;59(3):205-10. doi: 10.1016/j.critrevonc.2006.04.003. Epub 2006 Aug 14.
7
Implications of aging in surgical oncology.衰老在外科肿瘤学中的影响。
Cancer J. 2005 Nov-Dec;11(6):488-94. doi: 10.1097/00130404-200511000-00008.
8
Developing a cancer-specific geriatric assessment: a feasibility study.开展癌症特异性老年评估：一项可行性研究。
Cancer. 2005 Nov 1;104(9):1998-2005. doi: 10.1002/cncr.21422.
9
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.治疗前生活质量和功能状态评估能显著预测接受化疗的老年晚期非小细胞肺癌患者的生存期：意大利老年肺癌多中心研究的预后分析
J Clin Oncol. 2005 Oct 1;23(28):6865-72. doi: 10.1200/JCO.2005.02.527.
10
Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study.综合老年评估可预测晚期卵巢癌老年患者对化疗的耐受性及生存情况：一项法国国立癌症研究所妇科肿瘤组（GINECO）的研究
Ann Oncol. 2005 Nov;16(11):1795-800. doi: 10.1093/annonc/mdi368. Epub 2005 Aug 10.